Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 P645 | DOI: 10.1530/endoabs.90.P645

1Hedi Chaker-Department of Infectious Deseases, Sfax, Tunisia; 2Habib Bourguiba Laboratory Of Microbiology, Sfax, Tunisia


Purpose: Diabetes is a major risk factor for Staphylococcus aureus (SA) bacteremia. The purpose of this work is to study the epidemiological, clinical and microbiological profile of SA bacteremia in diabetics.

Patients and methods: Retrospective study conducted in the infectious diseases department of Sfax between January 2003 and April 2022 (19 years), including all diabetics admitted for SA bacteremia (at least one positive blood culture).

Results: Among 166 patients admitted for SA bacteremia, 72 were diabetic (43.3%). They were 38 men and 34 women, with an average age of 53 ± 19 years. Associated risk factors were catheterism (n=27) and surgery (n=8). Bacteremia was community-acquired (n=38) and nosocomial (n=34). The portal of entry was mainly endovascular (n=29) and cutaneous (n=28). Septic localizations were noted in 37 cases (51.4%), mainly bone (n=17), muscle (n=10), lung (n=7), joint (n=7), kidney (n=6) and neurological (n=6). Community strains and nosocomial strains were resistant to methicillin in 18% and 29% respectively. Antibiotic susceptibility was for fusidic acid (81%), rifampicin (80%), gentamicin (80%), ciprofloxacin (78%) and cotrimoxazole (69%). The mean duration of antibiotic therapy was 54 ± 30 days. The evolution was favorable in 96%.

Discussion: SA bacteraemia is frequent in diabetics and is characterized by the multitude and variety of septic localizations. SA meti-R is relatively common in nosocomial and community settings. Early and appropriate antibiotic therapy often guarantees a good evolution.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.